Closing the markets today with our friends from Vaccitech!
Based in Oxford, UK, Vaccitech develops vaccines and T cell immunotherapies to treat and prevent diseases of global importance.
Congratulations to CEO Bill Enright and #NasdaqListed $VACC on this week's listing.
Image: https://www.linkedin.com